about
Subtype specific elevated expression of hyaluronidase-1 (HYAL-1) in epithelial ovarian cancerAmplification and overexpression of the L-MYC proto-oncogene in ovarian carcinomasThe role of the breast cancer susceptibility gene 1 (BRCA1) in sporadic epithelial ovarian cancerOvarian cancer, the coagulation pathway, and inflammationRecent concepts of ovarian carcinogenesis: type I and type IIConditional inactivation of p53 in mouse ovarian surface epithelium does not alter MIS driven Smad2-dominant negative epithelium-lined inclusion cysts or teratomasType-specific cell line models for type-specific ovarian cancer researchGene expression data analysis in subtypes of ovarian cancer using covariance analysis.Loss of GATA4 and GATA6 expression specifies ovarian cancer histological subtypes and precedes neoplastic transformation of ovarian surface epitheliaCancer testis antigen vaccination affords long-term protection in a murine model of ovarian cancer.The biology of ovarian cancer: new opportunities for translationThe Müllerian HOXA10 gene promotes growth of ovarian surface epithelial cells by stimulating epithelial-stromal interactionsCathepsins B, L and cystatin C in cyst fluid of ovarian tumors.Characterization of MicroRNA-200 pathway in ovarian cancer and serous intraepithelial carcinoma of fallopian tube.The Functions of MicroRNA-200 Family in Ovarian Cancer: Beyond Epithelial-Mesenchymal Transition.Dickkopf-4 is frequently overexpressed in epithelial ovarian carcinoma and promotes tumor invasionCA125 in ovarian cancerAberrant expression of homeobox gene HOXA7 is associated with müllerian-like differentiation of epithelial ovarian tumors and the generation of a specific autologous antibody response.The tumour suppressor SOX11 is associated with improved survival among high grade epithelial ovarian cancers and is regulated by reversible promoter methylationEarly detection of ovarian cancerThe blood-follicle barrier (BFB) in disease and in ovarian function.Loss of cables, a novel gene on chromosome 18q, in ovarian cancer.Estrogen and androgen receptor expression in surface epithelium and inclusion cyst in the ovary of premenopausal and postmenopausal womenDevelopment of a syngeneic mouse model of epithelial ovarian cancer.Molecular genetic analysis of ovarian serous cystadenomas.Microenvironmental control of malignancy exerted by RNASET2, a widely conserved extracellular RNase.Multiple genetic alterations within the PI3K pathway are responsible for AKT activation in patients with ovarian carcinomaThe dominance of the microenvironment in breast and ovarian cancer.Potentially important microRNA cluster on chromosome 17p13.1 in primary peritoneal carcinoma.Prognostic relevance of acquired uniparental disomy in serous ovarian cancer.Disabled-2 heterozygous mice are predisposed to endometrial and ovarian tumorigenesis and exhibit sex-biased embryonic lethality in a p53-null backgroundTargeting HSP90 in ovarian cancers with multiple receptor tyrosine kinase coactivation.Fallopian tube correlates of ovarian serous borderline tumors.Molecular signature induced by RNASET2, a tumor antagonizing gene, in ovarian cancer cellsGab2 regulates the migratory behaviors and E-cadherin expression via activation of the PI3K pathway in ovarian cancer cellsExpression of folate receptors alpha and beta in normal and cancerous gynecologic tissues: correlation of expression of the beta isoform with macrophage markers.Genomic complexity and AKT dependence in serous ovarian cancer.Expression profiling in ovarian clear cell carcinoma: identification of hepatocyte nuclear factor-1 beta as a molecular marker and a possible molecular target for therapy of ovarian clear cell carcinomaGenome-wide significant risk associations for mucinous ovarian carcinomaAlpha2beta1 integrin affects metastatic potential of ovarian carcinoma spheroids by supporting disaggregation and proteolysis.
P2860
Q24307419-7E61F88C-8668-421D-B659-C7BCA38CB498Q24684274-9DBC546F-E9E8-4164-93FD-691FAA12F7ADQ24791520-1D0BF338-0AFF-4E8F-8C1E-FDC1D35418F3Q24816796-475C4E30-846C-435C-BD9F-5849D08AD858Q27009487-0F583296-89A4-4DBD-B29E-F7A7599FB678Q27317427-6D1A7073-7F84-4480-8302-8B8BFD576B4CQ28536689-39090801-5B43-4E1C-8A3F-DCBD663C4716Q31076542-C9A36C5F-1D4E-4A84-81F1-EAC7FE28E8E7Q33489525-3B3BF820-C4D8-4CAC-AC9E-EB5FD33BCD8EQ33582300-150FDF64-DF02-4489-9A94-3C78140A99B3Q33622369-E12AC042-3CD5-4DE4-AD6E-5F6F7C36E37EQ33624201-C6419685-E0A9-445E-85AF-BDCE8CEEEDC5Q33739577-A11B3A49-7B24-42DE-BC7B-B566517646CAQ33808368-41C40433-5467-40D4-A8B8-A0D89EBCC485Q33838714-3F2D7525-42AC-43F6-9422-5919D429206EQ33858856-59A7D933-26DB-4D07-A0C6-7F1FC56D6E6BQ33859857-623ADE43-7E7C-4C5F-99A2-BFC5A34773D0Q33953046-8E2935AE-948E-44FE-988A-F5FBB547A938Q34029565-7A8725C4-0DD5-4DA9-B3C6-43011E1BD47CQ34094731-66F82AEF-3578-4AC4-83A9-7C0D003271EAQ34216518-7B0EA9F0-FDAA-4010-91E3-C69BF4D0091EQ34247030-71FF0C57-4147-495F-B5DF-D36323BABC28Q34249388-40982431-8C4C-4632-B938-CBC649995235Q34282708-F1C4C45D-5546-4F36-9FDB-487DD99E3B3BQ34312494-BBF3CFA6-18BB-4EF2-95A3-FC17F8B999C0Q34508726-0CE9C920-0B0E-40FE-812A-E5C40F364099Q34586019-0E50890C-D1DC-4FAE-8234-4EF5175EF449Q34654993-6A40D250-DCD6-4064-8276-10BB0E6AA6D1Q34803840-E4EBE646-1994-4927-8400-332AD2955DC5Q35061331-200F3F4A-D0DF-46EC-8DF7-9AA641E09FEAQ35221856-0813A59B-6CAE-475A-A5F6-4172637CCF3CQ35390011-56625595-3F5D-4288-9280-39C277E157D1Q35560963-B538EA38-F7E2-41AC-977D-8377BE6C6D24Q35640277-DBB8192C-5C43-4D2A-8270-131E5742063DQ35683214-316D0176-1481-4BB6-BF30-5AA67AC1C5F0Q35730185-8E8681CE-DD56-43C0-A709-66B67FF49871Q35743316-5C40933D-410E-44BC-98F6-38AE1458C817Q35843312-EA7886B9-6D11-415A-81E7-044673B5AE68Q35904590-F1D0EF6D-C79F-41E0-B0B2-65A57CDF010BQ35906208-AD1DAA93-9DC1-425D-A891-D05BD1C0C5B1
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Precursor lesions of ovarian epithelial malignancy.
@ast
Precursor lesions of ovarian epithelial malignancy.
@en
Precursor lesions of ovarian epithelial malignancy.
@nl
type
label
Precursor lesions of ovarian epithelial malignancy.
@ast
Precursor lesions of ovarian epithelial malignancy.
@en
Precursor lesions of ovarian epithelial malignancy.
@nl
prefLabel
Precursor lesions of ovarian epithelial malignancy.
@ast
Precursor lesions of ovarian epithelial malignancy.
@en
Precursor lesions of ovarian epithelial malignancy.
@nl
P1433
P1476
Precursor lesions of ovarian epithelial malignancy.
@en
P2093
P356
10.1046/J.1365-2559.2001.01042.X
P577
2001-02-01T00:00:00Z